Expression of Cx43-related microRNAs in patients with tetralogy of Fallot
- 225 Downloads
- 9 Citations
Abstract
Background
Abnormal expression of connexin 43 (Cx43) has been reported to play an important role in the development of conotrunccal anomalies. However, less is known about the underlying reason for its abnormal expression. MicroRNAs (miRNAs), as an important part of gene expression regulation, have been implicated in some cardiac diseases. This study aimed to investigate the expression of Cx43 and its related miRNAs in patients with tetralogy of Fallot (TOF), and illustrate the potential role of abnormal miRNAs regulation to Cx43 expression in the pathology of TOF.
Methods
Real-time polymerase chain reaction (PCR) was used to detect the expression of Cx43 and 10 Cx43-related miRNAs in the myocardium from 30 TOF patients and 10 normal controls. Immunohistochemistry was used to detect Cx43 protein expression. Putative miRNA binding sites in the 3’UTR of Cx43 were examined in 200 TOF patients and 200 healthy individuals, using Sanger sequencing, to exclude sequence variations resulting in binding difficulties of miRNAs.
Results
Cx43 mRNA and protein expression in the myocardium tissue was significantly increased in TOF patients. The expression of MiR-1 and 206 was significantly decreased in the TOF patients as compared with the controls (P<0.05). No obvious difference was observed in the expression of the other 7 miRNAs between the TOF patients and controls (P>0.05). No meaningful sequence variation was detected in the putative miR1/206 binding sites in the 3’UTR of Cx43.
Conclusions
This study indicated that miR-1 and 206 is down-regulated in TOF patients, which may cause an up-regulation of Cx43 protein’s synthesis. It provided a clue that miR-1 and 206 might be involved in the pathogenesis of TOF, additional experiments are needed to determine if in fact, miR-1 and 206 contribute substantially to TOF.
Key words
congenital heart disease Cx43 miRNA tetralogy of FallotPreview
Unable to display preview. Download preview PDF.
References
- 1.Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:480–486.PubMedCrossRefGoogle Scholar
- 2.Apitz C, Webb GD, Redington AN. Tetralogy of Fallot. Lancet 2009;374:1462–1471.PubMedCrossRefGoogle Scholar
- 3.Karamlou T, McCrindle BW, Williams WG. Surgery insight: late complications following repair of tetralogy of Fallot and related surgical strategies for management. Nat Clin Pract Cardiovasc Med 2006;3:611–622.PubMedCrossRefGoogle Scholar
- 4.Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007;115:2995–3014.PubMedCrossRefGoogle Scholar
- 5.Ward C, Stadt H, Hutson M, Kirby ML. Ablation of the secondary heart field leads to tetralogy of Fallot and pulmonary atresia. Dev Biol 2005;284:72–83.PubMedCrossRefGoogle Scholar
- 6.Markwald R, Eisenberg C, Eisenberg L, Trusk T, Sugi Y. Epithelial-mesenchymal transformations in early avian heart development. Acta Anat (Basel) 1996;156:173–186.CrossRefGoogle Scholar
- 7.Miquerol L, Dupays L, Théveniau-Ruissy M, Alcoléa S, Jarry-Guichard T, Abran P, et al. Gap junctional connexins in the developing mouse cardiac conduction system. Novartis Found Symp 2003;250:80–98.PubMedCrossRefGoogle Scholar
- 8.Huang GY, Cooper ES, Waldo K, Kirby ML, Gilula NB, Lo CW. Gap junction-mediated cell-cell communication modulates mouse neural crest migration. J Cell Biol 1998;143:1725–1734.PubMedCentralPubMedCrossRefGoogle Scholar
- 9.Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281–297.PubMedCrossRefGoogle Scholar
- 10.Ambros V. The functions of animal microRNAs. Nature 2004;431:350–355.PubMedCrossRefGoogle Scholar
- 11.Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007;129:303–317.PubMedCrossRefGoogle Scholar
- 12.Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007;13:613–618.PubMedCrossRefGoogle Scholar
- 13.Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, et al. The musclespecific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007;13:486–491.PubMedCrossRefGoogle Scholar
- 14.Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010;18:510–525.PubMedCentralPubMedCrossRefGoogle Scholar
- 15.Cannell IG, Kong YW, Bushell M. How do microRNAs regulate gene expression? Biochem Soc Trans 2008;36:1224–1231.PubMedCrossRefGoogle Scholar
- 16.Nilsen TW. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet 2007;23:243–249.PubMedCrossRefGoogle Scholar
- 17.Eldadah ZA, Hamosh A, Biery NJ, Montgomery RA, Duke M, Elkins R, et al. Familial tetralogy of Fallot caused by mutation in the jagged1 gene. Hum Mol Genet 2001;10:163–169.PubMedCrossRefGoogle Scholar
- 18.Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation 2001;104:2565–2568.PubMedCrossRefGoogle Scholar
- 19.Pizzuti A, Sarkozy A, Newton AL, Conti E, Flex E, Digilio MC, et al. Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot. Hum Mutat 2003;22:372–377.PubMedCrossRefGoogle Scholar
- 20.Severs NJ. Gap junction remodeling and cardiac arrhythmogenesis: cause or coincidence? J Cell Mol Med 2001;5:355–366.PubMedCrossRefGoogle Scholar
- 21.Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, et al. Cardiac malformation in neonatal mice lacking connexin43. Science 1995;267:1831–1834.PubMedCrossRefGoogle Scholar
- 22.Barringhaus KG, Zamore PD. MicroRNAs: regulating a change of heart. Circulation 2009;119:2217–2224.PubMedCentralPubMedCrossRefGoogle Scholar
- 23.Anderson C, Catoe H, Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 2006;34:5863–5871.PubMedCentralPubMedCrossRefGoogle Scholar
- 24.Kwon C, Han Z, Olson EN, Srivastava D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signalling. Proc Natl Acad Sci U S A 2005;102:18986–18991.PubMedCentralPubMedCrossRefGoogle Scholar
- 25.Sokol NS, Ambros V. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev 2005;19:2343–2354.PubMedCentralPubMedCrossRefGoogle Scholar
- 26.Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005;436:214–220.PubMedCrossRefGoogle Scholar
- 27.O’Brien JE Jr, Kibiryeva N, Zhou XG, Marshall JA, Lofland GK, Artman M, et al. Noncoding RNA Expression In Myocardium from Infants withTetralogy of Fallot. Circ Cardiovasc Genet 2012;5:279–286.PubMedCrossRefGoogle Scholar
- 28.Townley-Tilson WH, Callis TE, Wang D. MicroRNAs 1, 133, and 206: Critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol 2010;42:1252–1255.PubMedCentralPubMedCrossRefGoogle Scholar
- 29.Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005;11:241–247.PubMedCentralPubMedCrossRefGoogle Scholar
- 30.Babak T, Zhang W, Morris Q, Blencowe BJ, Hughes TR. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA 2004;10:1813–1819.PubMedCentralPubMedCrossRefGoogle Scholar
- 31.Kelly M, Bagnall RD, Peverill RE, Donelan L, Corben L, Delatycki MB, et al. A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia. J Mol Cell Cardiol 2011;51:848–854.PubMedCrossRefGoogle Scholar
- 32.Uppugunduri CR. Possible involvement of microRNAs (miR-135a*) in heart failure associated with 25 bp deletion in MYBPC3 (cardiac myosin binding protein C) gene. Med Hypotheses 2011;76:306.PubMedCrossRefGoogle Scholar